PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15320779-7	2004	Recent data showed that in rats with left ventricular dysfunction after extensive myocardial infarction, eplerenone on top of ACE inhibition more effectively improved cardiac remodeling and molecular alterations than ACE inhibition alone.	Eplerenone	105-115	angiotensin I converting enzyme	Rattus norvegicus	217-220	
17903697-8	2007	Eplerenone or candesartan partially improved heart/body weight and cardiac fibrosis, improved EDR and decreased cardiac ACE and angiotensinogen mRNA levels in DS rats.	Eplerenone	0-10	angiotensin I converting enzyme	Rattus norvegicus	120-123	
18654024-7	2008	Eplerenone, a mineralocorticoid receptor antagonist, completely blocked the increase in ACE mRNA levels and the reduction in ACE2 mRNA levels due to aldosterone.	Eplerenone	0-10	angiotensin I converting enzyme	Rattus norvegicus	88-91	
14607457-7	2003	The addition of eplerenone to ACE inhibition prevented sarcoplasmic-reticulum calcium ATPase downregulation and the increases in LV gene expression of beta-MHC and atrial natriuretic factor more effectively than either monotherapy.	Eplerenone	16-26	angiotensin I converting enzyme	Rattus norvegicus	30-33